Targaxan® (rifaximin) launched in the UK for hepatic encephalopathy

Source: EMC Area: News Targaxan® (rifaximin) tablets have been launched in the UK for reducing recurrence of episodes of overt hepatic encephalopathy in adult patients. Rifaximin is already licensed in the UK as the brand name Xifaxanta® for the treatment of travellers' diarrhoea.   The NHS list price is £259.23 for 56 tablets
Source: NeLM - News - Category: Drugs & Pharmacology Source Type: news